AMICAS will continue our position as the leading independent provider of image and information management solutions in healthcare in partnership with Thoma Bravo.
AMICAS has signed a merger agreement with Thoma Bravo that will result in AMICAS becoming a private company. AMICAS supports the proposed transaction, which it believes is a win-win-win that provides compelling value for our shareholders, customers, and employees.
We believe that the transaction will enable us to bring renewed focus to our business, our solutions, our customers, and our employees, while developing a strong platform for continued success. Thoma Bravo has an excellent reputation and has a long history of partnering with existing management teams to build industry leading companies.
AMICAS represents Thoma Bravo's 14th platform investment in the software industry, and their goal is to work with existing management and employees to build the company into the industry leading independent provider of healthcare imaging technology.
- - -
JOIN US.
Questions? Contact Paul Merrild, senior vice president of marketing and business development at AMICAS, by e-mail at paul.merrild@amicas.com or by phone at 617.779.7704.
Information Regarding the Solicitation of Proxies:
In connection with the proposed transaction, AMICAS will file a proxy statement and relevant documents concerning the proposed transaction with the SEC. Shareholders of AMICAS are urged to read the proxy statement and other relevant materials when they become available because they will contain important information about AMICAS and the proposed transaction. Shareholders may obtain a free copy of the proxy statement and any other relevant documents filed by AMICAS with the SEC (when available) at the SEC's web site at http://www.sec.gov. In addition, shareholders may obtain free copies of the documents filed with the SEC by AMICAS by contacting AMICAS Investor Relations at colleen.mccormick@amicas.com or via telephone at 617-779-7892.
AMICAS and its directors and certain executive officers may be deemed to be participants in the solicitation of proxies from AMICAS shareholders in respect of the proposed transaction. Information about the directors and executive officers of AMICAS and their respective interests in AMICAS by security holdings or otherwise is set forth in its proxy statements and Annual Reports on Form 10-K, previously filed with the SEC, Investors may obtain additional information regarding the interest of the participants by reading the proxy statement regarding the acquisition when it becomes available. Each of these documents is, or will be, available for free at the SEC's web site at http://www.sec.gov and at the AMICAS Investor Relations web site at http://www.amicas.com/investorrelations/.
